Search Results - "Mileshkin, Linda"

Adjuvant chemotherapy for locally advanced cervical cancer – Authors' reply.

Authors: Mileshkin, Linda R Narayan, Kailash Gaffney, David K et al.

Source: Lancet Oncology. Jul2023, Vol. 24 Issue 7, pe290-e290. 1p.

Author Index.

Source: Psycho-Oncology. Mar2018 Supplement S2, Vol. 27, p29-30. 3p.

Subjects: Authors, Aaronson, Neil, Cummings, Amanda

Psychological distress, understanding of cancer and illness uncertainty in patients with Cancer of Unknown Primary.

Authors: Wolyniec, Kamil Sharp, Jessica Fisher, Krista et al.

Source: Psycho-Oncology. Nov2022, Vol. 31 Issue 11, p1869-1876. 8p. 2 Diagrams, 3 Charts.

Subjects: Cancer of unknown primary origin, Psychological distress, Cancer patients, Structural equation modeling, Sociodemographic factors

Cancer-of-Unknown-Primary-Origin: A SEER–Medicare Study of Patterns of Care and Outcomes among Elderly Patients in Clinical Practice.

Authors: Mileshkin, Linda Bochtler, Tilmann Gatta, Gemma et al.

Source: Cancers. Jun2022, Vol. 14 Issue 12, p2905-N.PAG. 14p.

Trends in phase 1 oncology clinical trials across Australia; Analysis of ClinicalTrials.gov 2012–2022.

Authors: Hitchen, Nadia Shahnam, Adel Manoharan, Sathya et al.

Source: Asia Pacific Journal of Clinical Oncology. Dec2024, Vol. 20 Issue 6, p731-737. 7p.

Understanding and information needs of cancer patients regarding treatment-focused genomic testing: A systematic review.

Authors: Wolyniec, Kamil Sharp, Jessica Lazarakis, Smaro et al.

Source: Psycho-Oncology. Apr2020, Vol. 29 Issue 4, p632-638. 7p. 1 Diagram.

Subjects: Tumor treatment, Systematic reviews, Genetic testing, Psychological tests, Health attitudes, Tumors, Psychological adaptation

Results of PD-L1 Analysis of Women Treated with Durvalumab in Advanced Endometrial Carcinoma (PHAEDRA).

Authors: Smith, Deborah Robledo, Kristy P. Yip, Sonia et al.

Source: Cancers. Jan2023, Vol. 15 Issue 1, p254. 10p.

Predicting durable remissions following thalidomide therapy for relapsed myeloma.

Authors: Quach, Hang Mileshkin, Linda Seymour, John F. et al.

Source: Leukemia & Lymphoma. Feb2009, Vol. 50 Issue 2, p223-229. 7p. 2 Charts, 4 Graphs.

Evaluating the Utility of ¹⁸F-FDG PET/CT in Cancer of Unknown Primary.

Authors: Sivakumaran, Tharani Cardin, Anthony Callahan, Jason et al.

Source: Journal of Nuclear Medicine. Oct2024, Vol. 65 Issue 10, p1557-1563. 7p.

We should not settle for low-level evidence but should always use the best available evidence.

Authors: Narayan, Kailash Mileshkin, Linda van Dyk, Sylvia et al.

Source: Journal of Gynecologic Oncology. 2014, Vol. 25 Issue 4, p349-351. 3p.

A qualitative study of patients with Cancer of Unknown Primary: Perceptions of communication, understanding of diagnosis and genomic testing, and information needs.

Authors: Wolyniec, Kamil O'Callaghan, Clare Fisher, Krista et al.

Source: Psycho-Oncology. Apr2023, Vol. 32 Issue 4, p589-596. 8p. 1 Diagram, 2 Charts.

Subjects: Cancer of unknown primary origin, Cancer patients, Patients' attitudes, Information needs, Family support, Communicative disorders

Corrigendum: Whole-genome characterization of chemoresistant ovarian cancer.

Authors: Patch, Ann-Marie Christie, Elizabeth L. Etemadmoghadam, Dariush et al.

Source: Nature. 11/19/2015, Vol. 527 Issue 7578, p398-398. 1p.

Subjects: Cancer genetics, Ovarian cancer, Genomes

Whole-genome characterization of chemoresistant ovarian cancer.

Authors: Patch, Ann-Marie Christie, Elizabeth L. Etemadmoghadam, Dariush et al.

Source: Nature. 5/28/2015, Vol. 521 Issue 7553, p489-494. 6p.

Subjects: Ovarian cancer, Cancer chemotherapy, Cancer genetics, Nucleotide sequence, BRCA genes

Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer.

Authors: Olawaiye, Alexander B. Jae-Weon Kim Bagameri, Andrea et al.

Source: Journal of Gynecologic Oncology. Jul2024, Vol. 35 Issue 4, p1-10. 10p.

Radiation with cisplatin or carboplatin for locally advanced cervix cancer: The experience of a tertiary cancer centre.

Authors: Au‐Yeung, George Mileshkin, Linda Bernshaw, David M et al.

Source: Journal of Medical Imaging & Radiation Oncology. Feb2013, Vol. 57 Issue 1, p97-104. 8p.

The Adjuvant Management of Endometrial Cancer: A Review of the Role of Systemic Therapy.

Authors: Mileshkin, Linda Jami, Shafaet

Source: European Journal of Clinical & Medical Oncology. 2011, Vol. 3 Issue 1, p1-11. 11p. 3 Charts.

The troublesome toxicity of peripheral neuropathy with thalidomide.

Authors: Mileshkin, Linda Prince, H. Miles

Source: Leukemia & Lymphoma. Nov2006, Vol. 47 Issue 11, p2276-2279. 4p.

The adverse prognostic impact of advanced age in multiple myeloma.

Authors: Mileshkin, Linda Prince, H. Miles

Source: Leukemia & Lymphoma. Jul2005, Vol. 46 Issue 7, p951-966. 16p.

The trajectory of patients who die from metastatic prostate cancer: a population‐based study.

Authors: Collins, Anna Sundararajan, Vijaya Millar, Jeremy et al.

Source: BJU International. May2019 Supplement S5, Vol. 123, p19-26. 8p.

Practical guidance on the use of olaparib capsules as maintenance therapy for women with BRCA mutations and platinum-sensitive recurrent ovarian cancer.

Authors: Friedlander, Michael Banerjee, Susana Mileshkin, Linda et al.

Source: Asia Pacific Journal of Clinical Oncology. Dec2016, Vol. 12 Issue 4, p323-331. 9p.